Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29;49(1):105.
doi: 10.1186/s13052-023-01516-6.

Clinical indicators that influence a clinician's decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia

Aslan Yilmaz  1 , Yavuz Ozer  2 , Nesrin Kaya  3 , Aydilek Dagdeviren Cakir  2 , Hazal Cansu Culpan  4 , Yildiz Perk  3 , Mehmet Vural  3 , Olcay Evliyaoglu  2
Affiliations

Clinical indicators that influence a clinician's decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia

Aslan Yilmaz et al. Ital J Pediatr. .

Erratum in

Abstract

Background: Transient hypothyroxinemia of prematurity (THOP) is defined as a low level of circulating thyroxine (T4), despite low or normal thyroid-stimulating hormone (TSH) levels.

Aims: We aimed to evaluate the incidence of THOP, the clinical and laboratory findings of preterm infants with this condition and the levothyroxine (L-T4) treatment.

Methods: Preterm infants (n = 181) delivered at 24-34 weeks of gestation were evaluated by their thyroid function tests that were performed between the 10th and 20th days of postnatal life and interpreted according to the gestational age (GA) references. Clinical and laboratory characteristics of the patients with THOP and normal thyroid function tests were compared. Patients with THOP and treated with L-T4 were compared with the ones who were not regarding laboratory, and clinical characteristics.

Results: Incidence of hypothyroxinemia of prematurity was 45.8% (n = 83). Euthyroidism, primary hypothyroidism, and subclinical hypothyroidism were diagnosed in 47.5% (n = 86), 5% (n = 9) and 1.7% (n = 3) of the patients, respectively. Mean birth weight (BW) and GA were significantly lower in the hypothyroxinemia group than in the euthyroid group (p < 0.001). L-T4 was started in 43% (n = 36) of the patients with THOP. Treatment initiation rate was 44.4% (n = 16) in 24-27 wk, 41.6% (n = 15) in 28-30 wk, and 13.8% (n = 5) in 31-34 wk. As the GA increased, the incidence of THOP and the rate of treatment initiation decreased (p < 0.001). The lowest free thyroxine (FT4) cut-off value was 0.72 ng/dl in the treated group. In addition, incidences of vancomycin + amikacin, caffeine, dopamine treatments, RDS, IVH, BPD, central catheter, FFP transfusion, and ventilator support were higher in the treated group (P < 0.05).

Conclusion: This study revealed that prevalence of THOP increased as the GA and BW decreased. As the GA decreased, THOP patients requiring L-T4 treatment increased. Additionally, association with comorbid diseases increased the requirement of treatment.

Keywords: Incidence; Preterm; Severity; Systematic review; Thyroid; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interests.

Figures

Fig. 1
Fig. 1
Distribution of all cases by week of gestation (data are given as numbers and %). Abbreviations: THOP, transient hypothyroxinemia of prematurity; GA, gestational age; TFT, thyroid function test
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Klein AH, Meltzer S, Kenny FM. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr. 1972;81:912–915. doi: 10.1016/s0022-3476(72)80542-0. - DOI - PubMed
    1. Ford G, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metab. 2014;28:175–187. doi: 10.1016/j.beem.2013.05.008. - DOI - PubMed
    1. Chung HR. Screening and management of thyroid dysfunction in preterm infants. Ann Pediatr Endocrinol Metab. 2019;24:15–21. doi: 10.6065/apem.2019.24.1.15. - DOI - PMC - PubMed
    1. van Trotsenburg P, Stoupa A, Léger J, et al. Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid. 2021;31:387–419. doi: 10.1089/thy.2020.0333. - DOI - PMC - PubMed
    1. Rose SR, Wassner AJ, Wintergerst KA, et al. Congenital Hypothyroidism: Screening and Management. Pediatrics. 2023;151(1):e2022060420. doi: 10.1542/peds.2022-060420. - DOI - PubMed